Viking Therapeutics Inc (VKTX)
42.03
-0.50
(-1.18%)
USD |
NASDAQ |
Jan 07, 14:49
Viking Therapeutics Research and Development Expense (TTM): 91.16M for Sept. 30, 2024
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
Amgen Inc | 5.774B |
Eli Lilly and Co | 10.53B |
Pfizer Inc | 10.60B |
Merck & Co Inc | 22.98B |
Vertex Pharmaceuticals Inc | 3.983B |